Abstract
BackgroundConsensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF)...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have